Print Submission Guidelines

The Maryland Law Review (MLR) takes pride in meticulously and fairly reviewing every manuscript submission that we receive. Our Executive Committee is responsible for selecting every article that we publish. Each article that receives an offer for publication is reviewed by the entire MLR Executive Committee. We prefer that you submit your manuscript through Scholastica, but we will also consider manuscripts submitted through email or hard copy. The Maryland Law Review prefers to review articles that are 25,000 words or less (including footnotes), but longer pieces will still be considered in many cases.

The Maryland Law Review uses a semi-blind review process for submissions. Our objective is to judge pieces based on their content and contribution to the legal academy. To accomplish this goal, submissions will be prescreened by our Manuscripts Editors in an un-blinded fashion. The Manuscripts Editors will have access to the author’s CV, cover letter, and other identifying information included with the manuscript. The most promising pieces will then be forwarded to the full MLR Executive Committee for their consideration. The MLR Executive Committee will not have access to the author’s CV or cover letter, and any identifying information within the manuscript will be redacted. The Executive Committee will cast preliminary votes in a blind fashion. Prior to the final Executive Committee vote, the author’s identifying information may be disclosed to the Executive Committee.

We ask that authors please submit their manuscripts without identifying information. Please note that if your piece includes citations referring to other works you authored but which do not identify that they are citations to your own work, you do not need to redact your name from them.

If you have any questions about the submission process, please do not hesitate to email us at mdlr01@law.umaryland.edu. We look forward to reviewing your submission.

Maryland Law Review is no longer accepting submissions for the 2024-2025 cycle.